Delivery Order SPE2DB20D2104-SPE2DB22FR28Z

Award Date 12/16/21
Potential Completion Date 12/17/21
Potential Value $1.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,761.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of 4568223554 - FLUOROURACIL 5% CREAM 40GM, with a period of performance extending through May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, valued at $2,336.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of FLUOROURACIL 5% CREAM 40GM, a medical product used for various healthcare applications. The contract has an ultimate completion date of November 18, 2024 and is structured as a Firm Fixed Price Delivery Order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fluorouracil 0.5% cream in 30 gram quantities. The $2,352.07 firm fixed-price delivery order was made under a broader Indefinite Delivery Contract (IDC) with Cencora, Inc. (doing business as Amerisourcebergen) valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorouracil 5% cream. The contract has a ceiling value of $1,793.25 and a performance period extending through April 11, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a substantial Indefinite Delivery Contract (IDC)...
The federal contract award SPE2DB20D3103|SPE2DB23FM7U5 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560272435 - Fluorouracil 5% Cream 40GM. The $1,385.83 firm fixed price delivery order has a completion date of March 16, 2023 and was awarded on March 15, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,516.68 firm fixed-price delivery order is for Fluorouracil 5% Cream, a medication used to treat certain types of skin cancer. The contract has an ultimate completion date of December 28, 2022 and was awarded on December 27, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.52 Firm Fixed Price Delivery Order is for the supply of 4558909963 - Fluorouracil 5% Cream, 40GM. The contract has an ultimate completion date of October 28, 2022 and was awarded on October 27, 2022. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $1,211.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorouracil 5% Cream, a prescription medication, with a performance period through May 4, 2023. The award is not designated as a set-aside and was issued as a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,069.47 fixed-price delivery order is for the supply of Fluorouracil 5% Cream, a pharmaceutical product. The contract has a period of performance ending on September 5, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,274.86 firm fixed-price contract is for the delivery of 4555497530 - Fluorouracil 0.5% Cream 30GM, a pharmaceutical product. The contract has a completion date of November 23, 2021 and was awarded on November 22, 2021. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FR28Z
    Delivery Order

This federal contract award is for the delivery of 4555731829 - FLUOROURACIL 5% CREAM 40GM to the Defense Logistics Agency (DLA). The contract, worth $1,805.14, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 16, 2021 with a completion date of December 17, 2021.

The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities through May 2024.

Generated 2/27/25, 10:03 AM